plat

(redirected from tissue plasminogen activator)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to tissue plasminogen activator: streptokinase

plat

A plan or survey map of a parcel of land.Developers file subdivision plats showing block and lot numbers, the dimensions and locations of individual lots, and the dimensions and locations of dedicated streets. Legal descriptions for properties within the subdivision are then made by reference to the recorded plat,such as “Lot 2,Block 3 of Harper Downs II as recorded in Plat Book 213,Page 82, of the Judge of Probate of Jefferson County,Alabama.”

References in periodicals archive ?
Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences.
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.
Spencer et al., "Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older," Mayo Clinic Proceedings, vol.
Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial.
The use of recombinant tissue plasminogen activator in the management of infective intracardiac thrombi in pre-term infants with thrombocytopaenia.
Cloning and expression of a human tissue plasminogen activator variant: [K.sub.2]S in Escherichia coli.
Analytes Control All CAD p value Fibrinogen 329.32 [+ or -] 443.24 [+ or -] 0.0253 (mg/dl) 13.93 30.11 t-PA (mg/dl) 10.92 [+ or -] 0.86 9.49 [+ or -] 0.71 0.2811 PAI-1 (mg/dl) 26.58 [+ or -] 6.15 45.06 [+ or -] 6.98 0.0466 TFPI-T (mg/dl) 56.11 [+ or -] 2.57 108.48 [+ or -] 6.99 0.0001 TFPI-F (mg/dl) 8.32 [+ or -] 0.67 18.94 [+ or -] 1.68 0.0004 Data is expressed as Mean [+ or -] SEM; Differences were studied by Mann-Whitney-test; Note: total (TFPI-T) & free (TFPI-F) tissue factor pathway inhibitor, plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator (t-PA).
Estimated Cost Savings of Increased Use of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Canada.
Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: feasibility and effectivity from an Indian perspective.
Less than one-third of acute stroke patients treated with the clot-busting drug, called intravenous tissue plasminogen activator (tPA), receive it within 60 minutes of their hospital arrival, according to research presented at the American Stroke Association's International Stroke Conference.